<DOC>
	<DOC>NCT00488787</DOC>
	<brief_summary>Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.</brief_summary>
	<brief_title>Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy patients at least 16 years of age requiring two or more third molar extractions Less than 16 years old Other exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>dental</keyword>
	<keyword>surgery</keyword>
	<keyword>analgesia</keyword>
	<keyword>2-4 impacted third molars</keyword>
</DOC>